---
figid: PMC5822899__IJE2018-2637418.001
figlink: /pmc/articles/PMC5822899/figure/fig1/
number: F1
caption: 'Schematic illustration of the main intracellular pathways and the effects
  of drugs used in dyslipidemia and obesity in (A) differentiation of preadipocytes
  into mature adipocytes. This process is on dependence of the PKA pathway, which
  activates transcriptional factors such as C/EBPB, C/EBPd, C/EBPa, and PPARG that
  ultimately lead to increase of adipogenesis gene expression. Statins and liraglutide
  inhibit adipogenesis while niacin and fibrates stimulate, by inducing upregulation
  of adipogenesis genes (∗leptin; adiponectin, FABP4, perilipin, and GLUT4, SCD1)
  expression and (B) immune and endocrine functions of WAT. Adipocyte exerts autocrine
  and paracrine actions, through secreting adipokines and also endocrine actions in
  distant organs. Most of the drugs exhibit an anti-inflammatory role through modulation
  of adipokine expression. Through modulation of leucocyte chemotaxis, they also affect
  NK cell activity and macrophage phagocytosis. See text for more details. →: stimulates;
  ⊣: inhibits; AC: adenylyl cyclase; cAMP: cyclic adenosine monophosphate; PKA: cAMP-dependent
  protein kinase A; C/EBP: CCATT enhancer-binding proteins; PPARs: peroxisome proliferator-activated
  receptors; SREBP1: sterol regulatory element-binding protein-1; RXTα: retinoid X
  receptor-α; SRE: sterol response elements; SRB1: scavenger receptor 1; NK cells:
  natural killer cells; CD40: cluster of differentiation 40; CD40L: CD40 ligand; 11B-HSD1:
  11B-Hydroxysteroid dehydrogenase type 1; TNFα: tumour necrosis factor α; IL: interleukin;
  CCL2 or MCP1: CC-chemokine ligand 2; PAI-1: plasminogen activator inhibitor type
  1; AdipoR: adiponectin receptor; IL1RA: IL1 receptor antagonist; IFN-γ: interferon-γ;
  TLR: Toll-like receptors; NFκB: nuclear factor kappa B; SRB1: scavenger receptor
  1; VCAM1: vascular cell adhesion molecule-1; E-selectin: endothelial-leukocyte adhesion
  molecule-1; ICAM1: intracellular adhesion molecule-1; OBRb: leptin receptor; ERK:
  extracellular signal-regulated kinase; MAPK: p38 mitogen-activated protein kinases;
  iNOS: inducible nitric oxide synthase; ROS: reactive oxygen species; TNFR: TNF receptor;
  IKKB: NFκB kinase-B; JNK: Jun N-terminal kinase; ER: endoplasmic reticulum; IR:
  insulin receptor (IR); IRS: insulin receptor substrate; UCP: uncoupling protein;
  CAP1: adenylyl cyclase-associated protein 1; ET1: endothelin-1.'
pmcid: PMC5822899
papertitle: 'Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose
  Tissue.'
reftext: Sofia Dias, et al. Int J Endocrinol. 2018;2018:2637418.
pmc_ranked_result_index: '226656'
pathway_score: 0.8415145
filename: IJE2018-2637418.001.jpg
figtitle: The main intracellular pathways and the effects of drugs used in dyslipidemia
  and obesity in (A) differentiation of preadipocytes into mature adipocytes
year: '2018'
organisms:
- Homo sapiens
ndex: ff14483d-df23-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5822899__IJE2018-2637418.001.html
  '@type': Dataset
  description: 'Schematic illustration of the main intracellular pathways and the
    effects of drugs used in dyslipidemia and obesity in (A) differentiation of preadipocytes
    into mature adipocytes. This process is on dependence of the PKA pathway, which
    activates transcriptional factors such as C/EBPB, C/EBPd, C/EBPa, and PPARG that
    ultimately lead to increase of adipogenesis gene expression. Statins and liraglutide
    inhibit adipogenesis while niacin and fibrates stimulate, by inducing upregulation
    of adipogenesis genes (∗leptin; adiponectin, FABP4, perilipin, and GLUT4, SCD1)
    expression and (B) immune and endocrine functions of WAT. Adipocyte exerts autocrine
    and paracrine actions, through secreting adipokines and also endocrine actions
    in distant organs. Most of the drugs exhibit an anti-inflammatory role through
    modulation of adipokine expression. Through modulation of leucocyte chemotaxis,
    they also affect NK cell activity and macrophage phagocytosis. See text for more
    details. →: stimulates; ⊣: inhibits; AC: adenylyl cyclase; cAMP: cyclic adenosine
    monophosphate; PKA: cAMP-dependent protein kinase A; C/EBP: CCATT enhancer-binding
    proteins; PPARs: peroxisome proliferator-activated receptors; SREBP1: sterol regulatory
    element-binding protein-1; RXTα: retinoid X receptor-α; SRE: sterol response elements;
    SRB1: scavenger receptor 1; NK cells: natural killer cells; CD40: cluster of differentiation
    40; CD40L: CD40 ligand; 11B-HSD1: 11B-Hydroxysteroid dehydrogenase type 1; TNFα:
    tumour necrosis factor α; IL: interleukin; CCL2 or MCP1: CC-chemokine ligand 2;
    PAI-1: plasminogen activator inhibitor type 1; AdipoR: adiponectin receptor; IL1RA:
    IL1 receptor antagonist; IFN-γ: interferon-γ; TLR: Toll-like receptors; NFκB:
    nuclear factor kappa B; SRB1: scavenger receptor 1; VCAM1: vascular cell adhesion
    molecule-1; E-selectin: endothelial-leukocyte adhesion molecule-1; ICAM1: intracellular
    adhesion molecule-1; OBRb: leptin receptor; ERK: extracellular signal-regulated
    kinase; MAPK: p38 mitogen-activated protein kinases; iNOS: inducible nitric oxide
    synthase; ROS: reactive oxygen species; TNFR: TNF receptor; IKKB: NFκB kinase-B;
    JNK: Jun N-terminal kinase; ER: endoplasmic reticulum; IR: insulin receptor (IR);
    IRS: insulin receptor substrate; UCP: uncoupling protein; CAP1: adenylyl cyclase-associated
    protein 1; ET1: endothelin-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PNPLA2
  - DGAT1
  - PRKAG1
  - NPPA
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - LPL
  - NR1H3
  - MGLL
  - MLXIPL
  - ALB
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKG1
  - TG
  - GC
  - SLC2A4
  - PDE3B
  - PRKAR1A
  - PRKAG3
  - PRKAA1
  - CLU
  - APOE
  - AKR1B10
  - PRKAG2
  - APOA2
  - PRKACB
  - PRKACG
  - ACACB
  - PRKACA
  - ACACA
  - APOA1
  - Orlistat
  - Gemfibrozil
  - Glucose
  - Acetyl-CoA
  - Malonyl
  - Pitavastatin
  - Acyl
  - CGMP
  - ATP
  - Catecholamines
  - Niacin
genes:
- word: ATGL
  symbol: ATGL
  source: hgnc_alias_symbol
  hgnc_symbol: PNPLA2
  entrez: '57104'
- word: DGAT
  symbol: DGAT
  source: hgnc_prev_symbol
  hgnc_symbol: DGAT1
  entrez: '8694'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ANP
  symbol: ANP
  source: hgnc_prev_symbol
  hgnc_symbol: NPPA
  entrez: '4878'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: LPL
  symbol: LPL
  source: hgnc_symbol
  hgnc_symbol: LPL
  entrez: '4023'
- word: LXRa
  symbol: LXR-a
  source: hgnc_alias_symbol
  hgnc_symbol: NR1H3
  entrez: '10062'
- word: MGL.
  symbol: MGL
  source: hgnc_alias_symbol
  hgnc_symbol: MGLL
  entrez: '11343'
- word: CHREBP
  symbol: CHREBP
  source: hgnc_alias_symbol
  hgnc_symbol: MLXIPL
  entrez: '51085'
- word: HDL
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: ALB
  entrez: '213'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: GC
  symbol: GC
  source: hgnc_symbol
  hgnc_symbol: GC
  entrez: '2638'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: PDE3B
  symbol: PDE3B
  source: hgnc_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: HDL
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: CLU
  entrez: '1191'
- word: HDL
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: HSI.
  symbol: HSI
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1B10
  entrez: '57016'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: HDL
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOA2
  entrez: '336'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: HDL
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOA1
  entrez: '335'
chemicals:
- word: Orlistat
  source: MESH
  identifier: C055122
- word: Gemfibrozil
  source: MESH
  identifier: D015248
- word: Glucose
  source: MESH
  identifier: D005947
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Malonyl
  source: MESH
  identifier: D008316
- word: Pitavastatin
  source: MESH
  identifier: C108475
- word: Acyl
  source: MESH
  identifier: D000214
- word: CGMP
  source: MESH
  identifier: C016276
- word: ATP
  source: MESH
  identifier: D000255
- word: Catecholamines
  source: MESH
  identifier: D002395
- word: Niacin
  source: MESH
  identifier: D009525
diseases: []
figid_alias: PMC5822899__F1
redirect_from: /figures/PMC5822899__F1
figtype: Figure
---
